Photodynamic therapy in non-subfoveal choroidal neovascularization secondary to pathological myopia: 1-Year outcome [13]

British Journal of Ophthalmology

Volumn 91, Issue 12, 2007, Pages 1722-1723

  Reche Frutos, Juan ^a,b   Calvo González, Cristina ^a   Donafe López, Juan ^a   García Feijoó, Julián ^a   Wasfy, M ^a   Saenz Frances, F ^a   Fernandez Perez, C ^a   Garcia Sanchez, J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CLINICAL ARTICLE; FEMALE; HUMAN; LETTER; MALE; MYOPIA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROGNOSIS; RETINA FOVEA; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AGED; CHOROIDAL NEOVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; FOVEA CENTRALIS; HUMANS; MALE; MIDDLE AGED; MYOPIA, DEGENERATIVE; PHOTOCHEMOTHERAPY; RETREATMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 36749090676     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.112045     Document Type: Letter

References (4)

1. Ohno-Matsui K, Yoshida T. Myopic choroidal neovascularization: natural course and treatment. Curr Opin Ophthalmol 2004;15:197- 202.
2. Hayashi K, Ohno-Matsui K, Yoshida T, et al. Characteristics of patients with a fovorable natural course of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 2005;243:13- 9.
3. Axer-Siegel R, Ehrlich R, Weinberger D, et al. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment. Am J Ophthalmol 2004;138:602-7.
4. Lam DS, Liu DT, Fan DS, et al. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia: 1 year results of a prospective series. Eye 2005;19:834- 40.